Target intelligence / Profile preview

Eukaryotic translation initiation factor 3 subunit E pseudogene 3 (EIF3EP3)

Target
EIF3EP3
Molecular classification
Other (pseudogene)
01

Overview

Eukaryotic translation initiation factor 3 subunit E pseudogene 3 (EIF3EP3) is classified as a pseudogene in the human genome[4][1]. Pseudogenes are genomic DNA sequences similar to normal genes but are non-functional; they are typically unable to encode functional proteins due to mutations or lack of regulatory elements. EIF3EP3 shares sequence homology with the protein-coding gene EIF3E, which is a true subunit of the eukaryotic translation initiation factor 3 (eIF3) complex. However, as a pseudogene, EIF3EP3 does not produce a functional protein and has no confirmed biological function, disease association, or drug interactions. It is not considered a therapeutic target[4][1]. Key points: - EIF3EP3 is not a receptor, enzyme, transporter, or recognized therapeutic target[4][1]. - No known associated biological functions, roles in disease, drug interactions, or use as a biomarker have been described for this pseudogene[4][1]. - The entry is likely included for genomic annotation purposes and should not be considered for drug development or therapeutic targeting. If a protein-coding gene is of interest, refer instead to Eukaryotic translation initiation factor 3 subunit E (EIF3E, also known as EIF3S6), which is functionally relevant in translation initiation[3][5].

Other names
ENGS00000277998Eukaryotic translation initiation factor 3, subunit E pseudogeneEukaryotic translation initiation factor 3 subunit E pseudogene 3EIF3E pseudogene 3EIF3EP3

Beyond the preview

Go deeper on Eukaryotic translation initiation factor 3 subunit E pseudogene 3 (EIF3EP3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Eukaryotic translation initiation factor 3 subunit E pseudogene 3 (EIF3EP3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call